MagIA Diagnostics develops portable, modular diagnostic tests that enable rapid screening of multiple parameters using just 50 µl of capillary blood, serum, plasma, or venous blood. The tests deliver results in 12-15 minutes, providing healthcare professionals with timely data for patient assessment and decision-making.
Funding
$7.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional laboratory testing often requires centralized equipment, limiting point-of-care testing capabilities and delaying time-to-results for clinicians. The need for rapid, on-site diagnostic information is critical in various healthcare settings, especially when immediate decisions impact patient outcomes.
Solution
MagIA Diagnostics offers a portable, modular diagnostic platform designed for rapid, multi-parameter screening at the point of care. The MforScreen analyzer utilizes single-use MagIA test cartridges to analyze 50 µl samples of capillary, serum, plasma, or venous blood, delivering results in 12-15 minutes. The system's compact design and extended battery life enable testing wherever it is needed, while recorded test results ensure traceability. The combined screening approach allows for up to 10 analyses per patient using two cartridges simultaneously, providing healthcare professionals with timely data for patient assessment and decision-making.
Target Audience
The primary target audience includes healthcare professionals requiring rapid, point-of-care diagnostic information, such as those in emergency rooms, intensive care units, and remote healthcare settings.
Features
- Portable analyzer weighing less than 3.5 kg with a >10-hour battery life
- Modular design supporting one or two test cartridges simultaneously
- Single-use MagIA test cartridges with integrated controls
- Combined screening capability of 5 analyses per cartridge
- Rapid results in 12-15 minutes
- Requires only 50 µl of capillary, serum, plasma, or venous blood
- Recorded test results for traceability